JANET VERNEY is Director of Operations at The Rothberg Institute. She holds a BS in Early Childhood Education and Administration from Charter Oak State College. Before coming to the Rothberg Institute, Janet was Director of Operations for 47 child care centers and nursery schools located throughout the Northeast. She has served as an educational and administrative consultant to area schools and organizations. She is a member of the National Association for the Education of Young Children and has filled many board positions in the Connecticut Affiliate and shoreline chapter.

BONNIE E. GOULD ROTHBERG MD, MPH currently serves as Director of Clinical Development at the Rothberg Institute for Childhood Diseases, a post she has held since joining TRI in 2002.  At TRI, Dr. Gould Rothberg is the Principal Investigator of the "Patients Learning About the Natural Evolution of Tuberous Sclerosis" (PLANETS) study of tuberous sclerosis natural history which has, to date, enrolled over 975 participants, the largest such study ever conducted.  Additionally, Dr. Gould Rothberg has just finished a 6-year term as Member of the Board of Directors of the Tuberous Sclerosis Alliance, the national non-profit organization championing the needs of TSC patients in the United States.  Dr. Gould Rothberg completed her B.A. from Cornell University Summa Cum Laude in the Biological Sciences and With Distinction in all Subjects in 1990 and received her Medical (1994) and Masters of Public Health Degrees (2005) from Yale University.  She is currently enrolled in the PhD program in Chronic Disease Epidemiology at Yale University.

WOLFGANG HINZ is a Senior Research Scientist in the chemistry division of The Rothberg Institute. He was educated at the University of Cape Town, South Africa after which he joined the chemistry department at Yale University for post-doctoral studies under the guidance of Prof. Kenneth Wiberg in June 2000. After completing a second post-doc with Prof. Karen Anderson and Prof. David Austin, he joined TRI July 2002.

SIVAKUMAR AATHIMANIKANDAN is a Postdoctoral Research Scientist in the chemistry division of The Rothberg Institute. He received his Ph.D., in Organic Synthesis from Indian Institute of Technology, Bombay in June 2002 under the guidance of Prof. Mrs. S.V. Bhat. His graduate research work focused mainly on asymmetric synthesis of biologically active molecules by using chiral sulfoxides as Vector. The efficacy of the sulfoxides was utilized in synthesizing chiral b-amino acids, b-amino-a-phenylethanol derivatives and a natural product Steganacin Lignan. After which he joined Dr. Thayumanavan’s research group as a Postdoctoral Research fellow initially at Tulane University, New Orleans in July 2002 and later at University of Massachusetts, Amherst in August 2003 for advanced research on Organic Macromolecular Materials. During his postdoctoral research, he worked in the design and synthesis of biomimetic materials (dendrimers & polymers) for targeted drug delivery and catalysis.  Sivakumar is currently working on finding active drug molecules through on-chip combinatorial synthesis and analysis to cure Tuberous Sclerosis Complex (TSC). Sivakumar joined TRI in June 2006.

GEFFREY STOPPER is a Postdoctoral Research Scientist with The Rothberg Institute.  He received his Bachelor’s degree in Biology from Hartwick College in Oneonta, NY, and his M.A. and Ph.D. from Yale University’s department of Ecology & Evolutionary Biology.  Geff’s doctoral studies focused on understanding the evolution of molecular mechanisms underlying pattern formation, particularly the sonic hedgehog pathway in the development of limb pattern in tetrapods.  Detecting and understanding the evolutionary or mutational genetic differences between individuals, especially as technology makes the genotypes of individuals increasingly accessible, is fundamental to understanding disease diagnosis and therapies.  Geff is currently working on methods to facilitate the identification of genotypic differences among individuals.  Geff joined TRI in April, 2007. 

FENG XU is a research associate at The Rothberg Institute. Feng received her bachelors degree in Applied Chemistry focusing on Medicine Chemistry from Wenzhou Normal College. She worked in the Institute of Developmental Biology and Molecular Medicine at Fadan University. Her major project was Effects of Chinese herbal extracts on tumor growth, especially on RAS gene. Feng joined TRI in February 2007.

JULIE GRIBBINS is an Administrative Assistant at The Rothberg Institute. She received a BA in English from the University of Connecticut in Storrs. Julie worked as a Billing Coordinator for NMC Homecare, a home IV–therapy company. She also worked as an Editor for both McGraw-Hill and The Globe Pequot Press. Julie joined TRI in November of 2004.

ADAM HUGHES is a Programmer/Computational Chemist at The Rothberg Institute.  He received his bachelor's degree in Chemistry and Math from DePauw University and his Ph. D. in Computational Physical Chemistry from Indiana University.  He has worked as a software engineer in the chemical informatics and high performance computing industries for the past several years.